Medscape |
Biologic-Based Asthma Treatment Gaining Momentum
Medscape DENVER — The monoclonal antibody dupilumab (Sanofi, Regeneron) improves lung function and reduces severe exacerbations in patients with asthma, according to results presented here at the American Thoracic Society 2015 International Conference … Regeneron speeds toward the FDA with its would-be asthma blockbuster Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in … Sanofi, Regeneron Announce Positive Phase 2 Data for Asthma Drug |
View full post on asthma – Google News